Im
Imago BioSciences
San Francisco CAFounded 201570 employees
Private CapbiotechAcquiredHematology
Platform: LSD1 MF
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Adagranaritide | IMA-8834 | Phase 2 | 2 | CD20 | PSPFTD | ||
| IMA-217 | IMA-217 | NDA/BLA | 1 | HER2 | HSWM |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (2)